Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Daniel Gryzlo"'
Publikováno v:
Neuro-Oncology
BACKGROUND Metronomic and targeted anti-angiogenesis therapy (MEMMAT) has emerged as a promising treatment for recurrent/progressive medulloblastoma. This treatment includes bevacizumab, oral agents (thalidomide, celecoxib, fenofibrate, etoposide & c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29f4b8daeaca8782c110fc8abe90266e
https://doi.org/10.1093/neuonc/noaa222.509
https://doi.org/10.1093/neuonc/noaa222.509
Autor:
Nundia Louis, Lihua Zou, Dusten Unruh, Patrick A. Ozark, Andrea Piunti, Vera Gorbunova, Xingyao He, Hiroaki Katagi, Daniel Gryzlo, Ali Zhang, Amanda M. Saratsis, Kathryn Laurie, Rishi Lulla, Jason Fangusaro, Craig Horbinski, Stewart Goldman, C David James, Ali Shilatifard, Rintaro Hashizume
INTRODUCTION: Focal radiation therapy has long been and remains the only treatment option for diffuse intrinsic pontine glioma (DIPG). However, all patients show evidence of disease progression within months of completing radiation therapy (RT). Sinc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1920b458fc9d0cbba36d8f54d1a5e76e
https://europepmc.org/articles/PMC6217190/
https://europepmc.org/articles/PMC6217190/
